𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In Vivo Interactions Between H2-Receptor Antagonists and Ethanol Metabolism in Man and in Rats

✍ Scribed by Helmut K. Seitz; Siegrid Veith; Peter Czygan; Johann Bösche; Bernd Simon; Roland Gugler; Burkhard Kommerell


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
460 KB
Volume
4
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The influence of a 7-day medication of either cimetidine (1,000 mg per day) or ranitidine (300 mg per day) on serum ethanol concentrations after a single oral dose of ethanol (0.8 gm per kg body weight) was investigated in a randomized placebo-controlled study in eight male volunteers. Compared with the placebo, cimetidine but not ranitidine produced a significant increase in both the peak serum ethanol concentration (85.9 +/- 3.5 vs. 73.0 +/- 3.2 mg dl-1, p less than 0.02) and in the area under the serum ethanol concentration time curve (350 +/- 19 vs. 304 +/- 25 mg dl-1 hr-1, p less than 0.05). However, the ethanol elimination rate was not affected by cimetidine. When ethanol (1.0 gm per kg body weight) was administered intravenously, cimetidine failed to induce a change in ethanol metabolism. Furthermore, the effect of H2-receptor antagonists was studied in animal experiments. Female Sprague-Dawley rats received a single dose of ethanol (7 or 3 gm per kg body weight) together with an intraperitoneal injection of either cimetidine (120 mg per kg body weight), ranitidine (120 mg per kg body weight) or isotonic saline. After alcohol absorption, ethanol elimination was significantly inhibited by both cimetidine (3.99 +/- 0.39 vs. 5.68 +/- 0.23 mmoles kg-1 hr-1, p less than 0.02) and ranitidine (4.21 +/- 0.14 vs. 5.68 +/- 0.23 mmoles kg-1 hr-1, p less than 0.02) at high ethanol concentrations (60 to 20 mM) but not at blood ethanol concentrations below 20 mM.(ABSTRACT TRUNCATED AT 250 WORDS)


📜 SIMILAR VOLUMES


Interactions between the flavonoid bioch
✍ Zhang, Shuzhong (author);Sagawa, Kazuko (author);Arnold, Robert D. (author);Tsen 📂 Article 📅 2010 🏛 John Wiley and Sons Inc 🌐 English ⚖ 197 KB 👁 1 views

The purpose of this study was to investigate the in vitro and in vivo interactions between flavonoids and P-glycoprotein (P-gp) substrates. The inhibitory effects of flavonoids on P-gp were determined by accumulation studies in P-gp-overexpressing MCF-7/ADR cells using daunomycin (DNM) as a model su

Hepatic adenine nucleotide metabolism me
✍ Kei Miyamoto; Samuel W. French 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 996 KB

Rats fed a diet high in fat and low in protein continuously infused by intragastric cannula were given ethanol for 2 to 6 months in order to examine the response of liver adenine nucleotides to changes in systemic POz. Hepatic adenine nucleotides were measured in vivo monthly using liver obtained by

The pharmacokinetics and metabolism of C
✍ Mary C. Allen; Mark R. Nocerini; Wesley W. Day 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16